Open Access 01-12-2020 | SARS-CoV-2 | Letter
Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19
Published in: Critical Care | Issue 1/2020
Login to get accessOpen Access 01-12-2020 | SARS-CoV-2 | Letter
Published in: Critical Care | Issue 1/2020
Login to get access